The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...
The global animal biotechnology market size is calculated at USD 30.97 billion in 2025 and is expected to reach around USD 72.6 billion by 2034, growing at a CAGR of 9.93% for the forecasted ...
Starting in 2026, NIBRT training will be piloted at Heartland BioWorks’ Indianapolis headquarters with hands-on training beginning in 2027.
Zacks Investment Research on MSN

Top 3 Genomics Stocks to Consider for Your Portfolio

An updated edition of the Sept. 18, 2025, article. Genomics is a comprehensive study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Given the recent promising breakthroughs ...
The food biotechnology market is projected to grow substantially over the next decade, rising from an estimated USD 32.5 ...
GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.
UK and ASEAN Strengthen Collaboration on Responsible Engineering Biology for a Sustainable Bioeconomy Bangkok, 10 November 2025 - The United Kingdom ...
With fresh tax relief and accelerating AI breakthroughs, select U.S. biotechs are entering a rare period of asymmetric upside ...
From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...
Predictive indicators for whether a child will be vulnerable to certain diseases after birth, as well as their future height, ...
What do agriculture and genetics have in common? We sat down with PhD candidate Harrison Estes to learn more about his unique ...
Sarepta Therapeutics said it received approval from the Food & Drug Administration to update prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy.